Skip to main content
Top
Published in: Immunity & Ageing 1/2009

Open Access 01-12-2009 | Research

Adverse environmental conditions influence age-related innate immune responsiveness

Authors: Linda May, Anita HJ van den Biggelaar, David van Bodegom, Hans J Meij, Anton JM de Craen, Joseph Amankwa, Marijke Frölich, Maris Kuningas, Rudi GJ Westendorp

Published in: Immunity & Ageing | Issue 1/2009

Login to get access

Abstract

Background-

The innate immune system plays an important role in the recognition and induction of protective responses against infectious pathogens, whilst there is increasing evidence for a role in mediating chronic inflammatory diseases at older age. Despite indications that environmental conditions can influence the senescence process of the adaptive immune system, it is not known whether the same holds true for the innate immune system. Therefore we studied whether age-related innate immune responses are similar or differ between populations living under very diverse environmental conditions.

Methods-

We compared cross-sectional age-related changes in ex vivo innate cytokine responses in a population living under affluent conditions in the Netherlands (age 20–68 years old, n = 304) and a population living under adverse environmental conditions in Ghana (age 23–95 years old, n = 562).

Results-

We found a significant decrease in LPS-induced Interleukin (IL)-10 and Tumor Necrosis Factor (TNF) production with age in the Dutch population. In Ghana a similar age-related decline in IL-10 responses to LPS, as well as to zymosan, or LPS plus zymosan, was observed. TNF production, however, did not show an age-associated decline, but increased significantly with age in response to co-stimulation with LPS and zymosan.

Conclusion-

We conclude that the decline in innate cytokine responses is an intrinsic ageing phenomenon, while pathogen exposure and/or selective survival drive pro-inflammatory responses under adverse living conditions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kwiatkowski D, Hill AV, Sambou I, Twumasi P, Castracane J, Manogue KR, Cerami A, Brewster DR, Greenwood BM: TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet. 1990, 336: 1201-1204. 10.1016/0140-6736(90)92827-5.CrossRefPubMed Kwiatkowski D, Hill AV, Sambou I, Twumasi P, Castracane J, Manogue KR, Cerami A, Brewster DR, Greenwood BM: TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet. 1990, 336: 1201-1204. 10.1016/0140-6736(90)92827-5.CrossRefPubMed
2.
go back to reference Kurtzhals JA, Adabayeri V, Goka BQ, Akanmori BD, Oliver-Commey JO, Nkrumah FK, Behr C, Hviid L: Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet. 1998, 351: 1768-1772. 10.1016/S0140-6736(97)09439-7.CrossRefPubMed Kurtzhals JA, Adabayeri V, Goka BQ, Akanmori BD, Oliver-Commey JO, Nkrumah FK, Behr C, Hviid L: Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet. 1998, 351: 1768-1772. 10.1016/S0140-6736(97)09439-7.CrossRefPubMed
3.
go back to reference Lyke KE, Burges R, Cissoko Y, Sangare L, Dao M, Diarra I, Kone A, Harley R, Plowe CV, Doumbo OK, Sztein MB: Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect Immun. 2004, 72: 5630-5637. 10.1128/IAI.72.10.5630-5637.2004.PubMedCentralCrossRefPubMed Lyke KE, Burges R, Cissoko Y, Sangare L, Dao M, Diarra I, Kone A, Harley R, Plowe CV, Doumbo OK, Sztein MB: Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect Immun. 2004, 72: 5630-5637. 10.1128/IAI.72.10.5630-5637.2004.PubMedCentralCrossRefPubMed
4.
go back to reference Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verweij CL, Boomsma DI, Vandenbroucke JP: Genetic influence on cytokine production and fatal meningococcal disease. Lancet. 1997, 349: 170-173. 10.1016/S0140-6736(96)06413-6.CrossRefPubMed Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verweij CL, Boomsma DI, Vandenbroucke JP: Genetic influence on cytokine production and fatal meningococcal disease. Lancet. 1997, 349: 170-173. 10.1016/S0140-6736(96)06413-6.CrossRefPubMed
5.
go back to reference Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G: Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000, 908: 244-254.CrossRefPubMed Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G: Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000, 908: 244-254.CrossRefPubMed
6.
go back to reference Bruunsgaard H, Pedersen AN, Schroll M, Skinhoj P, Pedersen BK: Impaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humans. Clin Exp Immunol. 1999, 118: 235-241. 10.1046/j.1365-2249.1999.01045.x.PubMedCentralCrossRefPubMed Bruunsgaard H, Pedersen AN, Schroll M, Skinhoj P, Pedersen BK: Impaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humans. Clin Exp Immunol. 1999, 118: 235-241. 10.1046/j.1365-2249.1999.01045.x.PubMedCentralCrossRefPubMed
7.
go back to reference Biggelaar van den AH, Huizinga TW, de Craen AJ, Gussekloo J, Heijmans BT, Frolich M, Westendorp RG: Impaired innate immunity predicts frailty in old age. The Leiden 85-plus study. Exp Gerontol. 2004, 39: 1407-1414. 10.1016/j.exger.2004.06.009.CrossRefPubMed Biggelaar van den AH, Huizinga TW, de Craen AJ, Gussekloo J, Heijmans BT, Frolich M, Westendorp RG: Impaired innate immunity predicts frailty in old age. The Leiden 85-plus study. Exp Gerontol. 2004, 39: 1407-1414. 10.1016/j.exger.2004.06.009.CrossRefPubMed
8.
go back to reference Romagnani S: Coming back to a missing immune deviation as the main explanatory mechanism for the hygiene hypothesis. J Allergy Clin Immunol. 2007, 119: 1511-1513. 10.1016/j.jaci.2007.04.005.CrossRefPubMed Romagnani S: Coming back to a missing immune deviation as the main explanatory mechanism for the hygiene hypothesis. J Allergy Clin Immunol. 2007, 119: 1511-1513. 10.1016/j.jaci.2007.04.005.CrossRefPubMed
9.
go back to reference Pawelec G, Derhovanessian E, Larbi A, Strindhall J, Wikby A: Cytomegalovirus and human immunosenescence. Rev Med Virol. 2009, 19: 47-56. 10.1002/rmv.598.CrossRefPubMed Pawelec G, Derhovanessian E, Larbi A, Strindhall J, Wikby A: Cytomegalovirus and human immunosenescence. Rev Med Virol. 2009, 19: 47-56. 10.1002/rmv.598.CrossRefPubMed
10.
go back to reference Gardner EM, Murasko DM: Age-related changes in Type 1 and Type 2 cytokine production in humans. Biogerontology. 2002, 3: 271-290. 10.1023/A:1020151401826.CrossRefPubMed Gardner EM, Murasko DM: Age-related changes in Type 1 and Type 2 cytokine production in humans. Biogerontology. 2002, 3: 271-290. 10.1023/A:1020151401826.CrossRefPubMed
11.
go back to reference Hartgers FC, Obeng BB, Kruize YC, Duijvestein M, de Breij A, Amoah A, Larbi IA, van Ree R, Wilson MD, Rodrigues LC, Boakye DA, Yazdanbakhsh M: Lower Expression of TLR2 and SOCS-3 Is Associated with Schistosoma haematobium Infection and with Lower Risk for Allergic Reactivity in Children Living in a Rural Area in Ghana. PLoS Negl Trop Dis. 2008, 2 (4): e227-10.1371/journal.pntd.0000227.PubMedCentralCrossRefPubMed Hartgers FC, Obeng BB, Kruize YC, Duijvestein M, de Breij A, Amoah A, Larbi IA, van Ree R, Wilson MD, Rodrigues LC, Boakye DA, Yazdanbakhsh M: Lower Expression of TLR2 and SOCS-3 Is Associated with Schistosoma haematobium Infection and with Lower Risk for Allergic Reactivity in Children Living in a Rural Area in Ghana. PLoS Negl Trop Dis. 2008, 2 (4): e227-10.1371/journal.pntd.0000227.PubMedCentralCrossRefPubMed
12.
go back to reference van der Kleij KD, van den Biggelaar AH, Kruize YC, Retra K, Fillie Y, Schmitz M, Kremsner PG, Tielens AG, Yazdanbakhsh M: Responses to Toll-like receptor ligands in children living in areas where schistosome infections are endemic. J Infect Dis. 2004, 189: 1044-1051. 10.1086/382089.CrossRefPubMed van der Kleij KD, van den Biggelaar AH, Kruize YC, Retra K, Fillie Y, Schmitz M, Kremsner PG, Tielens AG, Yazdanbakhsh M: Responses to Toll-like receptor ligands in children living in areas where schistosome infections are endemic. J Infect Dis. 2004, 189: 1044-1051. 10.1086/382089.CrossRefPubMed
13.
go back to reference Li Y, Howell EA, Lagoo AS, Kuchibhatla M, Pan H, Cohen HJ, Lagoo SA: Differential gene expression of interleukin-1 receptor associated kinase-1 and interleukin-1 receptor associated kinase-M in peripheral blood mononuclear cells of young and aged rats following preconditioning with endotoxin. Shock. 2009, 31: 55-63. 10.1097/SHK.0b013e3181778ab2.CrossRefPubMed Li Y, Howell EA, Lagoo AS, Kuchibhatla M, Pan H, Cohen HJ, Lagoo SA: Differential gene expression of interleukin-1 receptor associated kinase-1 and interleukin-1 receptor associated kinase-M in peripheral blood mononuclear cells of young and aged rats following preconditioning with endotoxin. Shock. 2009, 31: 55-63. 10.1097/SHK.0b013e3181778ab2.CrossRefPubMed
14.
go back to reference Paula C, Motta A, Schmitz C, Nunes CP, Souza AP, Bonorino C: Alterations in dendritic cell function in aged mice: potential implications for immunotherapy design. Biogerontology. 2009, 10: 13-25. 10.1007/s10522-008-9150-x.CrossRefPubMed Paula C, Motta A, Schmitz C, Nunes CP, Souza AP, Bonorino C: Alterations in dendritic cell function in aged mice: potential implications for immunotherapy design. Biogerontology. 2009, 10: 13-25. 10.1007/s10522-008-9150-x.CrossRefPubMed
15.
go back to reference Van Bodegom D, May L, Meij HJ, Westendorp RG: Regulation of human life histories: the role of the inflammatory host response. Ann N Y Acad Sci. 2007, 1100: 84-97. 10.1196/annals.1395.007.CrossRefPubMed Van Bodegom D, May L, Meij HJ, Westendorp RG: Regulation of human life histories: the role of the inflammatory host response. Ann N Y Acad Sci. 2007, 1100: 84-97. 10.1196/annals.1395.007.CrossRefPubMed
16.
go back to reference van Duin D, Shaw AC: Toll-like receptors in older adults. J Am Geriatr Soc. 2007, 55: 1438-1444. 10.1111/j.1532-5415.2007.01300.x.CrossRefPubMed van Duin D, Shaw AC: Toll-like receptors in older adults. J Am Geriatr Soc. 2007, 55: 1438-1444. 10.1111/j.1532-5415.2007.01300.x.CrossRefPubMed
17.
go back to reference Lord JM, Butcher S, Killampali V, Lascelles D, Salmon M: Neutrophil ageing and immunesenescence. Mech Ageing Dev. 2001, 122: 1521-1535. 10.1016/S0047-6374(01)00285-8.CrossRefPubMed Lord JM, Butcher S, Killampali V, Lascelles D, Salmon M: Neutrophil ageing and immunesenescence. Mech Ageing Dev. 2001, 122: 1521-1535. 10.1016/S0047-6374(01)00285-8.CrossRefPubMed
18.
go back to reference Stout RD, Suttles J: Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes. Immunol Rev. 2005, 205: 60-71. 10.1111/j.0105-2896.2005.00260.x.PubMedCentralCrossRefPubMed Stout RD, Suttles J: Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes. Immunol Rev. 2005, 205: 60-71. 10.1111/j.0105-2896.2005.00260.x.PubMedCentralCrossRefPubMed
20.
go back to reference Dolganiuc A, Norkina O, Kodys K, Catalano D, Bakis G, Marshall C, Mandrekar P, Szabo G: Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection. Gastroenterology. 2007, 133: 1627-1636. 10.1053/j.gastro.2007.08.003.PubMedCentralCrossRefPubMed Dolganiuc A, Norkina O, Kodys K, Catalano D, Bakis G, Marshall C, Mandrekar P, Szabo G: Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection. Gastroenterology. 2007, 133: 1627-1636. 10.1053/j.gastro.2007.08.003.PubMedCentralCrossRefPubMed
21.
go back to reference Cooke GS, Hill AV: Genetics of susceptibility to human infectious disease. Nat Rev Genet. 2001, 2: 967-977. 10.1038/35103577.CrossRefPubMed Cooke GS, Hill AV: Genetics of susceptibility to human infectious disease. Nat Rev Genet. 2001, 2: 967-977. 10.1038/35103577.CrossRefPubMed
22.
go back to reference Le Souef PN, Goldblatt J, Lynch NR: Evolutionary adaptation of inflammatory immune responses in human beings. Lancet. 2000, 356: 242-244. 10.1016/S0140-6736(00)02491-0.CrossRefPubMed Le Souef PN, Goldblatt J, Lynch NR: Evolutionary adaptation of inflammatory immune responses in human beings. Lancet. 2000, 356: 242-244. 10.1016/S0140-6736(00)02491-0.CrossRefPubMed
23.
24.
go back to reference Strong K, Mathers C, Leeder S, Beaglehole R: Preventing chronic diseases: how many lives can we save?. Lancet. 2005, 366: 1578-1582. 10.1016/S0140-6736(05)67341-2.CrossRefPubMed Strong K, Mathers C, Leeder S, Beaglehole R: Preventing chronic diseases: how many lives can we save?. Lancet. 2005, 366: 1578-1582. 10.1016/S0140-6736(05)67341-2.CrossRefPubMed
25.
go back to reference Meij JJ, de Craen AJ, Agana J, Plug D, Westendorp RG: Low-cost interventions accelerate epidemiological transition in Upper East Ghana. Trans R Soc Trop Med Hyg. 2009, 103: 173-178. 10.1016/j.trstmh.2008.09.015.CrossRefPubMed Meij JJ, de Craen AJ, Agana J, Plug D, Westendorp RG: Low-cost interventions accelerate epidemiological transition in Upper East Ghana. Trans R Soc Trop Med Hyg. 2009, 103: 173-178. 10.1016/j.trstmh.2008.09.015.CrossRefPubMed
26.
go back to reference Van Bodegom D, May L, Kuningas M, Kaptijn R, Thomese F, Meij HJ, Amankwa J, Westendorp RG: Socio-economic status by rapid appraisal is highly correlated with mortality risks in rural Africa. Trans R Soc Trop Med Hyg. 2009, Van Bodegom D, May L, Kuningas M, Kaptijn R, Thomese F, Meij HJ, Amankwa J, Westendorp RG: Socio-economic status by rapid appraisal is highly correlated with mortality risks in rural Africa. Trans R Soc Trop Med Hyg. 2009,
27.
go back to reference Ziem JB, Spannbrucker N, Magnussen P, Olsen A, mon-Kotey DN, Frenzel K, Nang-Beifubah A, Westendorp RG, Polderman AM: Oesophagostomum bifurcum-induced nodular pathology in a highly endemic area of Northern Ghana. Trans R Soc Trop Med Hyg. 2005, 99: 417-422. 10.1016/j.trstmh.2004.07.008.CrossRefPubMed Ziem JB, Spannbrucker N, Magnussen P, Olsen A, mon-Kotey DN, Frenzel K, Nang-Beifubah A, Westendorp RG, Polderman AM: Oesophagostomum bifurcum-induced nodular pathology in a highly endemic area of Northern Ghana. Trans R Soc Trop Med Hyg. 2005, 99: 417-422. 10.1016/j.trstmh.2004.07.008.CrossRefPubMed
28.
go back to reference de Craen AJ, Posthuma D, Remarque EJ, Biggelaar van den AH, Westendorp RG, Boomsma DI: Heritability estimates of innate immunity: an extended twin study. Genes Immun. 2005, 6: 167-170. 10.1038/sj.gene.6364162.CrossRefPubMed de Craen AJ, Posthuma D, Remarque EJ, Biggelaar van den AH, Westendorp RG, Boomsma DI: Heritability estimates of innate immunity: an extended twin study. Genes Immun. 2005, 6: 167-170. 10.1038/sj.gene.6364162.CrossRefPubMed
30.
go back to reference Linden van der MW, Huizinga TW, Stoeken DJ, Sturk A, Westendorp RG: Determination of tumour necrosis factor-alpha and interleukin-10 production in a whole blood stimulation system: assessment of laboratory error and individual variation. J Immunol Methods. 1998, 218: 63-71. 10.1016/S0022-1759(98)00108-2.CrossRefPubMed Linden van der MW, Huizinga TW, Stoeken DJ, Sturk A, Westendorp RG: Determination of tumour necrosis factor-alpha and interleukin-10 production in a whole blood stimulation system: assessment of laboratory error and individual variation. J Immunol Methods. 1998, 218: 63-71. 10.1016/S0022-1759(98)00108-2.CrossRefPubMed
31.
go back to reference May L, van Bogedom D, Kuningas M, Meij JJ, de Craen AJ, Frölich M, Westendorp RG: Performance of the whole-blood stimulation assay for assessing innate immune activation under field conditions. Cytokine. 2009, 45: 184-189. 10.1016/j.cyto.2008.12.010.CrossRefPubMed May L, van Bogedom D, Kuningas M, Meij JJ, de Craen AJ, Frölich M, Westendorp RG: Performance of the whole-blood stimulation assay for assessing innate immune activation under field conditions. Cytokine. 2009, 45: 184-189. 10.1016/j.cyto.2008.12.010.CrossRefPubMed
32.
go back to reference Westenbrink BD, Stienstra Y, Huitema MG, Thompson WA, Klutse EO, Ampadu EO, Boezen HM, Limburg PC, Werf van der TS: Cytokine responses to stimulation of whole blood from patients with Buruli ulcer disease in Ghana. Clin Diagn Lab Immunol. 2005, 12: 125-129.PubMedCentralPubMed Westenbrink BD, Stienstra Y, Huitema MG, Thompson WA, Klutse EO, Ampadu EO, Boezen HM, Limburg PC, Werf van der TS: Cytokine responses to stimulation of whole blood from patients with Buruli ulcer disease in Ghana. Clin Diagn Lab Immunol. 2005, 12: 125-129.PubMedCentralPubMed
Metadata
Title
Adverse environmental conditions influence age-related innate immune responsiveness
Authors
Linda May
Anita HJ van den Biggelaar
David van Bodegom
Hans J Meij
Anton JM de Craen
Joseph Amankwa
Marijke Frölich
Maris Kuningas
Rudi GJ Westendorp
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Immunity & Ageing / Issue 1/2009
Electronic ISSN: 1742-4933
DOI
https://doi.org/10.1186/1742-4933-6-7

Other articles of this Issue 1/2009

Immunity & Ageing 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.